Cachexia News and Research

RSS
Cachexia is a condition which denotes the excessive loss of weight. It occurs because of the depletion of adipose tissue and muscle mass in people who are not trying to lose weight.
Selective manipulation of enzyme can stop cancer cachexia

Selective manipulation of enzyme can stop cancer cachexia

Researchers discover new role of cellular signaling molecule involved in release of hunger hormone

Researchers discover new role of cellular signaling molecule involved in release of hunger hormone

New gene therapeutic approach could save people suffering from muscle wasting disease

New gene therapeutic approach could save people suffering from muscle wasting disease

Why does appetite loss occur during illness? An interview with Prof. Conti and Prof. Francesconi

Why does appetite loss occur during illness? An interview with Prof. Conti and Prof. Francesconi

Mitofusin 2 protein could serve as therapeutic target to ameliorate sarcopenia in older adults

Mitofusin 2 protein could serve as therapeutic target to ameliorate sarcopenia in older adults

Scientists discover how immune system molecule hijacks brain circuit to reduce appetite during illness

Scientists discover how immune system molecule hijacks brain circuit to reduce appetite during illness

Mouse-based study shows exercise decreases cancer incidence, slows tumor growth

Mouse-based study shows exercise decreases cancer incidence, slows tumor growth

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

UofL researchers discover mechanism involved in skeletal muscle repair

UofL researchers discover mechanism involved in skeletal muscle repair

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

Helsinn one step closer to bringing anamorelin HCI to market for treatment of anorexia, cachexia in NSCLC patients

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Experimental drug may stop life-threatening muscle wasting associated with advanced cancers

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

Researchers discover new gene that could be a potential therapeutic target for muscle wasting

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Helsinn, BIAL sign exclusive distribution and licence agreement for Anamorelin

Scientists decipher new molecular signaling path that prompts protein degradation in muscle

Scientists decipher new molecular signaling path that prompts protein degradation in muscle

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Gastrostomy methods equivalent in amyotrophic lateral sclerosis

Moderate exercise on a regular basis may improve cancer treatments

Moderate exercise on a regular basis may improve cancer treatments

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Helsinn, Mundipharma sign distribution and license agreement for anamorelin

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

Anamorelin drug safe and well tolerated in advanced non-small cell lung cancer, Phase III trial reveals

Scientists discover sign of early development of pancreatic cancer

Scientists discover sign of early development of pancreatic cancer